Blog: 23andMe vs. the FDA part 1: analyzing the arguments
This blog post was written by Deniz Temelli, Business Analyst at TechAlliance. Early last week, the FDA sent Google-backed genetics testing company 23andMe a letter ordering them to halt sales and marketing of their Personal Genome Service (PGS). As part of this service, a customer sends the company a saliva sample from which 900,000 base…